- Home
- USLM vs VKTX Comparison
USLM vs VKTX Comparison
Compare USLM & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USLM | VKTX |
|---|---|---|
| Founded | 1948 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | USLM | VKTX |
|---|---|---|
| Price | $120.40 | $36.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $87.07 |
| AVG Volume (30 Days) | 67.7K | ★ 3.8M |
| Earning Date | 10-29-2025 | 10-22-2025 |
| Dividend Yield | ★ 0.20% | N/A |
| EPS Growth | ★ 32.23 | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | ★ $364,849,000.00 | N/A |
| Revenue This Year | $22.64 | N/A |
| Revenue Next Year | $8.38 | N/A |
| P/E Ratio | $26.72 | ★ N/A |
| Revenue Growth | ★ 20.27 | N/A |
| 52 Week Low | $80.47 | $18.92 |
| 52 Week High | $157.20 | $54.54 |
Technical Indicators
Market Signals| Indicator | USLM | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 53.17 |
| Support Level | $118.65 | $32.90 |
| Resistance Level | $125.00 | $43.15 |
| Average True Range (ATR) | 3.30 | 2.25 |
| MACD | 0.67 | -0.45 |
| Stochastic Oscillator | 45.77 | 35.90 |
Price Performance
Historical ComparisonAbout USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.